• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

测量危重症患者血浆中游离与总哌拉西林浓度:方法学问题与意义。

Measuring Unbound Versus Total Piperacillin Concentrations in Plasma of Critically Ill Patients: Methodological Issues and Relevance.

机构信息

Department of Laboratory Medicine, Ghent University Hospital, Ghent, Belgium.

Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.

出版信息

Ther Drug Monit. 2019 Jun;41(3):325-330. doi: 10.1097/FTD.0000000000000602.

DOI:10.1097/FTD.0000000000000602
PMID:30633089
Abstract

BACKGROUND

Piperacillin is considered a moderately protein-bound antibiotic (20%-40%), with albumin being an important binding protein. Although infrequently used in practice, different methods to measure the fraction unbound (fu) are available, but uncertainty remains as to what the most appropriate method is. The main goal of this study was to estimate the impact of the methodology used to measure unbound piperacillin in plasma on the fu of piperacillin; we compared ultrafiltration (UF) at 4°C and 37°C with the reference method, equilibrium dialysis. In addition, we analyzed the impact of other proteins on the fu.

METHODS

Anonymized left-over Li-heparin plasma samples (n = 41) from 30 critically ill patients who were treated with piperacillin were used for the analyses.

RESULTS

We found that the piperacillin fu, determined by UF, is on average 8% higher at 37°C (91%) than at 4°C (83%). There were no systematic or proportional differences between UF at 4°C and equilibrium dialysis at 4°C. This emphasizes the importance of the temperature during UF, which should therefore be clearly stated in publications that report on the methodology of UF. No significant impact of the albumin-, IgA-, total protein-, or α1-acid glycoprotein concentration on the fu was found. The fu found in this study was higher than the generally assumed fu value of 60%-80%. A possible explanation lies in the studied population or in the temperature used. Based on our results, routine monitoring of unbound piperacillin in intensive care unit patients is not recommended.

CONCLUSIONS

Based on the prediction model, we can state that in intensive care patients the fu of piperacillin is 91% (SD 7%), determined with UF at 37°C.

摘要

背景

哌拉西林被认为是一种中等程度结合蛋白的抗生素(20%-40%),白蛋白是其重要的结合蛋白。尽管在实践中很少使用,但有不同的方法来测量未结合分数(fu),但仍不确定哪种方法最合适。本研究的主要目的是评估测量血浆中未结合哌拉西林的方法对哌拉西林 fu 的影响;我们比较了 4°C 和 37°C 的超滤(UF)与参考方法平衡透析。此外,我们还分析了其他蛋白对 fu 的影响。

方法

使用来自 30 名接受哌拉西林治疗的危重症患者的匿名左肝素锂血浆样本(n = 41)进行分析。

结果

我们发现,37°C 时 UF 测定的哌拉西林 fu 平均比 4°C 时高 8%(91%)。UF 在 4°C 时与平衡透析在 4°C 时之间没有系统或比例差异。这强调了 UF 过程中温度的重要性,因此在报告 UF 方法的出版物中应明确说明温度。白蛋白、IgA、总蛋白或α1-酸性糖蛋白浓度对 fu 没有显著影响。本研究中发现的 fu 值高于通常假设的 60%-80%的 fu 值。一种可能的解释在于所研究的人群或所使用的温度。基于我们的结果,不建议常规监测 ICU 患者的未结合哌拉西林。

结论

根据预测模型,我们可以说在重症监护患者中,37°C 时 UF 测定的哌拉西林 fu 为 91%(SD 7%)。

相似文献

1
Measuring Unbound Versus Total Piperacillin Concentrations in Plasma of Critically Ill Patients: Methodological Issues and Relevance.测量危重症患者血浆中游离与总哌拉西林浓度:方法学问题与意义。
Ther Drug Monit. 2019 Jun;41(3):325-330. doi: 10.1097/FTD.0000000000000602.
2
Measuring unbound versus total vancomycin concentrations in serum and plasma: methodological issues and relevance.测量血清和血浆中万古霉素的游离浓度与总浓度:方法学问题及相关性
Ther Drug Monit. 2015 Apr;37(2):180-7. doi: 10.1097/FTD.0000000000000122.
3
Reproducible Quantification of Unbound Fractions of Four Beta-Lactam Antibiotics: Ultrafiltration Versus Microdialysis of Spiked Healthy Donor Plasma.可重复定量分析四种β-内酰胺类抗生素的游离分数:加标健康供体血浆的超滤与微透析法比较。
Ther Drug Monit. 2023 Feb 1;45(1):45-54. doi: 10.1097/FTD.0000000000001016.
4
Meropenem, Cefepime, and Piperacillin Protein Binding in Patient Samples.美罗培南、头孢吡肟和哌拉西林在患者样本中的蛋白结合率。
Ther Drug Monit. 2020 Feb;42(1):129-132. doi: 10.1097/FTD.0000000000000675.
5
Rapid equilibrium dialysis, ultrafiltration or ultracentrifugation? Evaluation of methods to quantify the unbound fraction of substances in plasma.快速平衡透析、超滤还是超速离心?评估定量血浆中物质未结合分数的方法。
Biochem Biophys Res Commun. 2023 Apr 9;651:114-120. doi: 10.1016/j.bbrc.2023.02.021. Epub 2023 Feb 10.
6
Piperacillin Population Pharmacokinetics in Critically Ill Adults During Sustained Low-Efficiency Dialysis.哌拉西林在持续低效透析的危重症成人中的群体药代动力学。
Ann Pharmacother. 2018 Oct;52(10):965-973. doi: 10.1177/1060028018773771. Epub 2018 May 7.
7
Unbound fraction of ertapenem in intensive care unit patients.重症监护病房患者中厄他培南的游离分数
J Antimicrob Chemother. 2014 Nov;69(11):3108-11. doi: 10.1093/jac/dku226. Epub 2014 Jun 23.
8
Pharmacokinetics of piperacillin and tazobactam in plasma and subcutaneous interstitial fluid in critically ill patients receiving continuous venovenous haemodiafiltration.哌拉西林他唑巴坦在接受连续性静脉-静脉血液透析滤过的危重症患者血浆和皮下组织间液中的药代动力学。
Int J Antimicrob Agents. 2014 Apr;43(4):343-8. doi: 10.1016/j.ijantimicag.2014.01.009. Epub 2014 Feb 10.
9
Teicoplanin binding in plasma following administration of increasing intravenous doses to healthy volunteers.
Eur J Drug Metab Pharmacokinet. 1991;Spec No 3:256-60.
10
Repeated Piperacillin-Tazobactam Plasma Concentration Measurements in Severely Obese Versus Nonobese Critically Ill Septic Patients and the Risk of Under- and Overdosing.严重肥胖与非肥胖重症感染性患者哌拉西林-他唑巴坦血浆浓度的重复测量及用药不足和过量风险
Crit Care Med. 2017 May;45(5):e470-e478. doi: 10.1097/CCM.0000000000002287.

引用本文的文献

1
Population Pharmacokinetic Modeling of Piperacillin/Tazobactam in Healthy Adults and Exploration of Optimal Dosing Strategies.哌拉西林/他唑巴坦在健康成年人中的群体药代动力学建模及最佳给药策略探索。
Pharmaceuticals (Basel). 2025 Jul 27;18(8):1124. doi: 10.3390/ph18081124.
2
Interprofessional Therapeutic Drug Monitoring of Piperacillin/Tazobactam Enhances Care for Patients with Acute-on-Chronic Liver Failure in the ICU: A Retrospective Observational Pilot Study.哌拉西林/他唑巴坦的跨专业治疗药物监测改善了重症监护病房中急性慢性肝衰竭患者的护理:一项回顾性观察性试点研究。
Antibiotics (Basel). 2025 Feb 14;14(2):202. doi: 10.3390/antibiotics14020202.
3
Individualization of piperacillin dosage based on therapeutic drug monitoring with or without model-informed precision dosing: a scenario analysis.
基于治疗药物监测(无论有无模型指导的精准给药)的哌拉西林剂量个体化:情景分析
J Antimicrob Chemother. 2025 Mar 3;80(3):840-847. doi: 10.1093/jac/dkaf007.
4
Serum Concentration at 24 h With Intensive Beta-Lactam Therapy in Sepsis and Septic Shock: A Prospective Study: Beta-Lactam Blood Levels in Sepsis.脓毒症和脓毒性休克强化β-内酰胺类治疗24小时时的血清浓度:一项前瞻性研究:脓毒症中的β-内酰胺类血药浓度
Crit Care Res Pract. 2024 Oct 21;2024:9757792. doi: 10.1155/2024/9757792. eCollection 2024.
5
Development and validation of an UPLC-MS/MS assay for the simultaneous quantification of seven commonly used antibiotics in human plasma and its application in therapeutic drug monitoring.建立并验证了一种超高效液相色谱-串联质谱法(UPLC-MS/MS),用于同时定量检测人血浆中的七种常用抗生素,并将其应用于治疗药物监测。
J Antimicrob Chemother. 2024 Apr 2;79(4):883-890. doi: 10.1093/jac/dkae047.
6
Exposure levels and target attainment of piperacillin/tazobactam in adult patients admitted to the intensive care unit: a prospective observational study.成人重症监护病房患者哌拉西林/他唑巴坦的暴露水平和目标达成率:一项前瞻性观察研究。
Can J Anaesth. 2024 Apr;71(4):511-522. doi: 10.1007/s12630-023-02689-8. Epub 2024 Jan 19.
7
Towards model-informed precision dosing of piperacillin: multicenter systematic external evaluation of pharmacokinetic models in critically ill adults with a focus on Bayesian forecasting.朝向哌拉西林的模型指导下精准给药:以贝叶斯预测为重点,对危重症成年患者的药代动力学模型进行多中心系统外部评估。
Intensive Care Med. 2023 Aug;49(8):966-976. doi: 10.1007/s00134-023-07154-0. Epub 2023 Jul 13.
8
Pathogen-based target attainment of optimized continuous infusion dosing regimens of piperacillin-tazobactam and meropenem in surgical ICU patients: a prospective single center observational study.外科重症监护病房患者中哌拉西林-他唑巴坦和美罗培南优化持续输注给药方案基于病原体的目标达成情况:一项前瞻性单中心观察性研究
Ann Intensive Care. 2023 Apr 29;13(1):35. doi: 10.1186/s13613-023-01129-6.
9
The Influence of Extracorporeal Membrane Oxygenation on Antibiotic Pharmacokinetics.体外膜肺氧合对抗生素药代动力学的影响
Antibiotics (Basel). 2023 Mar 2;12(3):500. doi: 10.3390/antibiotics12030500.
10
Evaluation of a Meropenem and Piperacillin Monitoring Program in Intensive Care Unit Patients Calls for the Regular Assessment of Empirical Targets and Easy-to-Use Dosing Decision Tools.对重症监护病房患者美罗培南和哌拉西林监测项目的评估需要定期评估经验性目标和易于使用的给药决策工具。
Antibiotics (Basel). 2022 Jun 2;11(6):758. doi: 10.3390/antibiotics11060758.